Additionally, we investigate whether assessing vimentin expression in preoperative samples could help improve the identification of patients with high-risk disease, including lymph node metastases, in a large international multicentre patient series [13]. The gene discussed is VIM; the disease is metastatic malignant neoplasm in the lymph nodes.